Blood Transfusion in Dogs and Cats: Crossmatching and Compatibility

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Canine blood transfusions are primarily guided by the DEA 1 system, with DEA 1.1 being the most clinically significant due to its high immunogenicity and potential for acute hemolytic reactions in previously sensitized dogs. Crossmatching is mandatory for dogs with a history of prior transfusion or pregnancy to detect antibodies against less common antigens like Dal.
• Feline blood transfusions are critically dependent on the AB system, where type B cats possess potent naturally occurring anti-A alloantibodies, making type A blood transfusion life-threatening. Blood typing is essential for all feline transfusions, and crossmatching is recommended to mitigate risks associated with weaker anti-B antibodies in type A cats and the rare Mik antigen.
• Crossmatching, encompassing both major (recipient plasma vs. donor red cells) and minor (donor plasma vs. recipient red cells) components, is crucial for detecting serologic incompatibility. The major crossmatch is paramount for identifying antibodies likely to cause hemolysis of transfused cells, while the minor crossmatch is particularly relevant in cats due to strong anti-A antibodies in type B donors.
• Point-of-care typing and crossmatching methods, including card agglutination, gel column technology, and immunochromatographic strips, are available for both species. Gel column technology offers standardized results and reduced technical variability compared to traditional tube methods.
• In emergency situations where immediate transfusion is required and crossmatching is not feasible, blood typing alone may be used for first-time transfusion recipients with no prior sensitization history. However, this carries residual risk, especially in cats, and necessitates close monitoring for transfusion reactions.
• Xenotransfusion of canine blood to cats is a high-risk salvage procedure reserved for situations where no compatible feline blood is available, often resulting in acute intravascular hemolysis and poor outcomes.

This article provides a procedural reference for pre-transfusion testing in dogs and cats, covering blood group systems, typing methods, and crossmatch interpretation. It is written for practicing veterinarians who select donors, perform compatibility testing, or interpret results submitted to reference laboratories. The focus is confined to testing and compatibility, transfusion administration, product selection, and reaction management are covered in companion articles.

Safe transfusion practice depends on understanding the immunologic basis of blood group incompatibility and on performing the correct test for the clinical scenario. Blood typing identifies the patient's antigen profile, while crossmatching detects serologic incompatibility between a specific donor and recipient pair. These tests answer different questions, and each has distinct limitations that affect clinical decision-making.

At a Glance

Canine Blood Group Systems

More than a dozen red cell antigen systems have been recognized in dogs, classified as dog erythrocyte antigens (DEA). The DEA 1 system is the most clinically significant. It includes two major subtypes, DEA 1.1 and DEA 1.2, which behave as alleles. Dogs are either DEA 1 positive or negative, and DEA 1 positive dogs may express 1.1, 1.2, or both. The clinical importance of DEA 1.1 is well established: a dog previously sensitized to DEA 1.1 can develop an acute hemolytic transfusion reaction when re-exposed, characterized by fever, pigmenturia, and failure of the packed cell volume to rise as expected. This reaction is mediated by a specific IgG alloantibody with high hemolysin and agglutinin activity, as documented in a case report of a dog transfused three years after initial sensitization.

Dogs do not possess clinically significant naturally occurring alloantibodies. This means a first transfusion is unlikely to cause an acute hemolytic reaction even without typing. The risk arises after sensitization, which can occur from a single prior transfusion, pregnancy, or possibly from prior exposure to blood products. For this reason, crossmatching is strongly recommended for any dog with a history of prior transfusion.

Additional canine antigens, including DEA 3, 4, 5, and 7, can elicit alloantibody production after sensitization. The Dal antigen was identified when a Dalmatian developed alloantibodies to a common red cell antigen after transfusion, with major crossmatch incompatibility to 55 non-Dalmatian donors. Approximately 25 of unrelated Dalmatians lacked the same antigen, indicating that Dal-negative status is not restricted to a single family line. These findings demonstrate that standard typing panels do not capture all clinically relevant canine antigens, and that crossmatching remains necessary even when donor and recipient match for the commonly tested DEA types.

Feline Blood Group Systems

The AB system is the only recognized feline blood group system. It comprises three types: A, B, and AB. Type A is most common in domestic shorthair cats, while type B frequency varies geographically and by breed. Type AB is rare. The AB system differs fundamentally from canine systems because cats possess naturally occurring alloantibodies. Type B cats have strong anti-A alloantibodies, and transfusion of type A blood into a type B cat produces a life-threatening acute hemolytic reaction. Type A cats have weaker anti-B antibodies, but incompatible transfusion still carries risk.

A fourth feline antigen, Mik, has been described in cats that developed transfusion reactions despite AB-compatible blood. Mik testing is not widely available in commercial panels, which reinforces the need for crossmatching in all feline transfusions.

Blood Typing Methods

Commercial typing methods include card agglutination, gel column technology, and immunochromatographic strip assays. These point-of-care methods are readily available for both dogs and cats. Gel column technology, adapted from human blood banking, offers standardized reading and reduced technician variability compared to tube methods. Immunochromatographic strips detect specific antigens and include a control band that confirms test validity.

A notable limitation of strip-based DEA 1 typing is that the positive control band may be absent in feline blood, which paradoxically allows identification of transfused canine red cells in a cat that received a xenotransfusion. This observation, reported in a study of anemic cats receiving canine blood, illustrates both the cross-reactivity of some reagents and the value of understanding test mechanics when interpreting unusual results.

Crossmatching Principles

Crossmatching detects antibodies in the recipient's plasma against donor red cells (major crossmatch) and antibodies in the donor's plasma against recipient red cells (minor crossmatch). The major crossmatch is the more clinically important test because it identifies the antibodies most likely to cause hemolysis of transfused cells. The minor crossmatch matters when donor plasma contains significant alloantibodies, which is particularly relevant in cats because type B donor plasma contains strong anti-A antibodies.

Tube agglutination methods are technically demanding and require careful attention to sample collection, handling, and identification. Gel column crossmatching provides a point-of-care alternative that is less technically demanding and has become available for use in dogs and cats. Crossmatching reduces the risk of hemolytic transfusion reactions but does not eliminate the risk of other transfusion reaction types, and all reactions should be documented and investigated.

Limitations of Compatibility Testing

Crossmatching cannot detect all potential incompatibilities. Delayed hemolytic reactions, non-hemolytic febrile reactions, and allergic reactions are not reliably predicted by crossmatch results. In cats, the presence of naturally occurring alloantibodies means that crossmatching is mandatory even when blood types appear matched. In dogs, a negative crossmatch does not guarantee absence of sensitization to antigens not represented on the donor panel, particularly when the recipient has a history of prior transfusion or pregnancy.

The evidence base for some compatibility decisions remains limited. Xenotransfusion of canine blood to cats has been reported as a salvage procedure when compatible feline blood is unavailable, but the outcomes in reported cases were poor, with acute intravascular hemolysis and rapid decline in packed cell volume. This practice should not be considered a routine alternative to feline blood products.

Step-by-Step Crossmatch Protocol

The major crossmatch detects recipient antibodies directed against donor red blood cells. The minor crossmatch detects donor antibodies directed against recipient red blood cells. Both should be performed whenever time permits, although the major crossmatch carries greater clinical weight because recipient antibodies are the principal cause of hemolytic transfusion reactions.

Sample Collection and Preparation

Collect blood from both recipient and donor into EDTA tubes for red cell suspension preparation and into plain or serum separator tubes for plasma or serum. Label every tube with patient identification, date, and collector initials at the time of collection. Mislabelled samples are a leading source of pretransfusion error, and proper sample identification is imperative for high-quality testing.

Centrifuge the EDTA samples to separate plasma from red cells. Prepare a 2% to 5% red cell suspension by washing the packed cells three times in isotonic saline, then diluting to the desired concentration. Use the recipient's plasma and donor red cells for the major crossmatch, and donor plasma with recipient red cells for the minor crossmatch.

Tube Method

The tube agglutination method remains the reference technique and requires no specialized equipment beyond a centrifuge, saline, and test tubes.

1. Place two drops of recipient plasma in a labelled tube and add one drop of donor red cell suspension. This is the major crossmatch.
2. Place two drops of donor plasma in a second tube and add one drop of recipient red cell suspension. This is the minor crossmatch.
3. Include an auto-control using recipient plasma with recipient red cells to detect autoagglutination or pre-existing antibody coating.
4. Incubate the tubes at 37°C for 15 to 30 minutes.
5. Centrifuge briefly and examine the cell button for agglutination or hemolysis.
6. Gently resuspend the button and grade the reaction from negative to 4+.

Hemolysis in the supernatant is a positive result and must not be ignored. It indicates complement activation and carries the same significance as agglutination.

Gel Column Method

A commercial gel agglutination system adapted from human blood banking is available for dogs and cats. This method uses pre-filled gel columns containing anti-canine or anti-feline globulin reagents. Diluted plasma and red cell suspensions are pipetted into the gel columns, incubated, and centrifuged. Agglutinated red cells are trapped in the gel while unagglutinated cells pellet to the bottom.

The gel method is less technically demanding than the tube method and produces more standardized results. It is suitable for practices that perform crossmatches infrequently or where staff have limited experience with tube agglutination interpretation.

Interpretation and Decision Points

A compatible major crossmatch shows no agglutination or hemolysis. An incompatible result, regardless of grade, indicates that the selected donor unit should not be transfused. Test a second donor unit if one is available.

The auto-control is essential for correct interpretation. If the auto-control is positive, the recipient's red cells are already coated with antibody or the sample shows cold agglutination. In this setting, a positive major crossmatch may reflect the recipient's underlying condition instead of true donor incompatibility, and the result must be interpreted with caution.

Donor Selection Criteria

Donor selection begins with blood typing and extends to crossmatching against the specific recipient. A typed donor that is antigen-negative for the relevant blood group is preferred, but crossmatching remains necessary because additional blood group systems exist beyond those routinely typed.

Canine Donor Selection

For dogs, DEA 1.1 negative donors are the standard choice because DEA 1.1 is the most immunogenic canine blood group system. A previously sensitized dog can develop anti-DEA 1.1 antibodies that cause acute hemolytic transfusion reactions upon subsequent exposure to DEA 1.1 positive blood. Crossmatching previously transfused dogs is mandatory, and using DEA 1.1 negative donors reduces this risk.

The Dal blood group system illustrates why crossmatching cannot be replaced by typing alone. A Dalmatian sensitized by prior transfusion developed alloantibodies to a common red cell antigen that was absent in some Dalmatians but present in most other dogs. This antigen, later designated Dal, is not detected by standard typing panels. Only crossmatching identified the incompatibility.

Feline Donor Selection

Feline donor selection is governed by the AB blood group system. Type B cats possess strong naturally occurring anti-A alloantibodies, and transfusion of type A blood into a type B cat produces life-threatening acute hemolytic transfusion reactions. Type A cats have weaker anti-B antibodies, but AB-matched transfusion remains the standard of care.

Type AB cats are universal recipients because they lack both anti-A and anti-B alloantibodies. However, they can only donate to other type AB cats, as their red cells express both A and B antigens.

When Crossmatching Is Not Possible

In an emergency where the recipient's condition precludes waiting for a full crossmatch, blood typing alone may guide donor selection. A first-time transfusion recipient with no history of prior transfusion or pregnancy is at lower risk of pre-formed alloantibodies. However, this approach carries residual risk, particularly in cats, where naturally occurring alloantibodies are present without prior sensitization.

Xenotransfusion with canine blood in cats has been described in emergency situations when compatible feline blood was unavailable. This practice produced transient clinical improvement followed by acute intravascular hemolysis and rapid decline in packed cell volume. Xenotransfusion should be considered only as a last resort when no feline blood products exist, and the owner must be informed of the high risk of severe reaction.

Documentation and Record Keeping

Every pretransfusion test result must be recorded in the medical record with sufficient detail to support clinical decisions. Record the blood type of both donor and recipient, the crossmatch method used, the results of major and minor crossmatches, the auto-control result, and the identity of the specific donor unit tested.

Include the date and time of testing, the technician or veterinarian who performed the test, and the lot number of any commercial reagents used. This documentation supports investigation if a transfusion reaction occurs later, and it provides a baseline for interpreting future transfusions in the same patient.

Species-Specific Considerations

Cats present a higher risk of potentially fatal transfusion reactions than dogs because of the strength of their naturally occurring alloantibodies. The decision to transfuse and the product selected depend on the type of anemia, the patient's cardiovascular status, and the availability of typed and crossmatched blood.

Dogs with a history of prior transfusion or pregnancy should always be crossmatched, even when the donor is DEA 1.1 negative. The immune system can produce antibodies to multiple red cell antigens, and prior sensitization may not be predictable from typing alone.

Patient status changes the testing approach. A hemodynamically unstable patient may require transfusion before crossmatch results are available. In this situation, use a typed, previously untransfused donor and begin the transfusion slowly while monitoring for signs of reaction. The crossmatch can be completed during the transfusion, and the transfusion stopped if incompatibility is detected.

Equipment availability also changes the correct choice. Practices without a centrifuge can use gel column technology, which requires only the commercial kit and a dedicated centrifuge supplied by the manufacturer. Practices with limited caseload may prefer to send blood typing and crossmatching to an external laboratory, accepting the delay in turnaround time.

Recognized Complications and Early Detection

The most serious compatibility failure is an acute hemolytic transfusion reaction. In dogs, DEA 1.1 incompatibility in a previously sensitized recipient can produce fever, pigmenturia, lethargy, and a failure of the packed cell volume to rise as expected, as documented in a report of an acute hemolytic reaction in a sensitized dog. Detection begins before administration: a major crossmatch should be performed on every previously transfused dog, and the recipient's historical transfusion record reviewed. During transfusion, the earliest indicators are often a rising temperature, tachycardia, or pigmenturia, and the transfusion should be stopped immediately if any of these appear.

In cats, the risk is greater because of naturally occurring alloantibodies. A type B cat receiving type A blood can develop life-threatening acute hemolysis, so blood typing and crossmatching are mandatory before any feline transfusion. Delayed serological reactions, in which alloantibodies develop days after transfusion, are harder to detect clinically but should be suspected when anemia recurs or the recipient requires repeated transfusion.

Common Errors and Corrective Actions

Sample misidentification is the most frequent preventable error. Tubes must be labelled at the bedside with the patient's name and the date, and the crossmatch worksheet must record the donor unit number and the recipient's identity. A second clinician should verify the match before blood is released.

Inadequate sample handling produces false results. Hemolysed or lipaemic samples interfere with agglutination readings, and samples stored for more than 24 hours may yield unreliable crossmatch results. Centrifuge the sample promptly, separate the plasma, and store it refrigerated if testing is delayed. The gel column method is less technically demanding than the tube method, but it still requires careful pipetting and correct incubation times.

A common error in cats is assuming that a type A cat can receive type A blood without crossmatching. This is unsafe because type A cats may have weak anti-B alloantibodies, and type AB cats have no alloantibodies but are rare. Crossmatching should be performed even when blood types appear compatible.

Students and less experienced clinicians often confuse the major and minor crossmatch. The major crossmatch tests recipient plasma against donor red cells and is the critical test for hemolytic reactions. The minor crossmatch tests donor plasma against recipient red cells and is less important in dogs and cats, but it should still be read and recorded.

Limitations of Current Evidence

The evidence base for veterinary transfusion compatibility is built largely on case reports, small series, and expert opinion instead of controlled trials. The canine blood group system is incompletely characterized, and more than a dozen systems have been recognized, some of which are not classified as DEA antigens. The clinical significance of several of these antigens is unknown, and a compatible crossmatch does not guarantee that no incompatibility exists.

Expert opinion differs on the value of the minor crossmatch, on whether universal donor programs are preferable to type-specific donors, and on the need for crossmatching in first-time transfusion recipients. Some authorities recommend crossmatching all recipients, while others accept blood typing alone for a first transfusion in a dog. The risk of sensitization after a single transfusion is real, and a previously transfused dog should always be crossmatched.

Xenotransfusion, the use of canine blood in cats, has been reported in emergency situations when feline blood is unavailable. In one report, two anemic cats with blood compatibility issues received canine blood and improved transiently, but both developed acute intravascular hemolysis and the transfused red cells were cleared within four days. This practice carries a high risk of severe reactions and should be reserved for situations where no feline blood is available and the owner understands the risks.

Referral and Escalation

Referral to a specialist or a veterinary blood bank should be considered when the recipient has a history of transfusion reactions, when the crossmatch is incompatible with all available donors, or when the patient requires repeated transfusions. A veterinary clinical pathologist or transfusion medicine specialist can assist with complex serological investigations, including autoantibody detection and the identification of unusual alloantibodies.

External laboratory involvement is appropriate when in-house typing and crossmatching results are discordant, when the patient has a rare blood type, or when a delayed hemolytic reaction is suspected. Laboratories can perform extended typing, including DEA 1.1, 1.2, 3, 4, 5, and 7, and can provide gel column crossmatching with standardized reagents.

Regulatory reporting is rarely required for transfusion reactions in small animals, but clinicians should be aware of local requirements. In some regions, adverse events associated with blood products may be reportable to a veterinary pharmacovigilance program. The AVMA provides practice resources that can help clinicians locate current guidance on reporting and on blood banking standards. Where blood products are collected and administered under a practice-based program, the practice should have a written protocol for documenting and investigating all transfusion reactions, as recommended in reviews of pretransfusion testing.

Frequently Asked Questions

How should I proceed when a crossmatch is incompatible but transfusion is still necessary?

An incompatible major crossmatch indicates a high risk of hemolytic transfusion reaction, particularly in cats with naturally occurring alloantibodies. Recheck the result for technical error, confirm recipient and donor sample identity, and retype both animals. If incompatibility persists, test additional donors to find a compatible unit. When no compatible donor exists, weigh the risk of withholding transfusion against the risk of reaction. In cats, mismatched transfusion can be rapidly fatal, so exhausting all donor options is mandatory. In dogs, incompatible crossmatches are less predictable because many alloantibodies require prior sensitization. Document the decision, the alternatives considered, and the owner's informed consent before proceeding.

Can I use a blood typing card result alone to select a donor without performing a crossmatch?

Blood typing and crossmatching answer different questions. Typing identifies the major blood group antigens, while crossmatching detects antibodies in the recipient's plasma against donor red cells. A type-matched donor can still be crossmatch-incompatible, especially in previously transfused or pregnant animals. The risk is higher in cats because naturally occurring alloantibodies exist even without prior exposure. Crossmatching reduces the risk of hemolytic transfusion reactions but does not eliminate all transfusion risks. When a crossmatch is unavailable, type-matched blood is preferable to unmatched blood, but the residual risk must be acknowledged and the recipient monitored closely during administration.

What is the minimum equipment needed to perform an in-house crossmatch?

A standard tube method requires only a centrifuge, saline, test tubes, and a source of recipient plasma and donor red cells. No specialized commercial kit is necessary. The major crossmatch tests recipient plasma against donor red cells, and the minor crossmatch tests donor plasma against recipient red cells. An autocontrol using recipient plasma and recipient red cells helps distinguish true incompatibility from autoagglutination. Gel column technology offers a point-of-care alternative that is less technically demanding than tube methods. Practices that cannot perform either method should use blood typing alone and source donors from established blood banks that have already screened for common antigens.

How do I explain crossmatch results to an owner when the recommended donor is incompatible?

Owners need to understand that incompatibility does not mean the blood is "bad" but that the recipient's immune system may attack the donor's red cells. Explain that a major crossmatch incompatibility carries a risk of acute hemolysis, fever, and potentially life-threatening reactions. In cats, emphasize that type B cats have strong antibodies against type A blood and can die from a mismatched transfusion. Describe the steps being taken to find a compatible donor, including testing additional animals or contacting a blood bank. If no compatible donor exists, present the options honestly: proceed with the least incompatible unit under close monitoring, consider alternative treatments such as synthetic colloids or erythropoiesis-stimulating agents, or refer to a specialty center.

What documentation should accompany a transfusion when a crossmatch is performed?

Record the recipient's blood type, the donor's blood type, the crossmatch method used, and the results of major, minor, and autocontrol tests. Note the date, the person performing the test, and the specific donor unit identification. Document any discrepancy between typing and crossmatch results. If a crossmatch was not performed, record the reason and the risk assessment that justified proceeding. This record supports post-transfusion investigation if a reaction occurs and guides future transfusion decisions, since sensitized patients may develop antibodies that were not previously detectable. The AVMA practice resources emphasize that accurate medical records support continuity of care and patient safety.

Does the crossmatch procedure differ between dogs and cats?

The procedural steps are similar, but the interpretation differs because of species-specific antibody biology. Cats have naturally occurring alloantibodies against the AB system, so an incompatible major crossmatch is expected when blood types are mismatched and carries a high risk of acute hemolysis. Dogs generally lack clinically significant naturally occurring alloantibodies, so a positive crossmatch in a previously untransfused dog is unexpected and warrants investigation. Sensitized dogs can develop antibodies after transfusion or pregnancy, and these may cause acute hemolytic reactions on subsequent exposure. The Dal blood type, identified in Dalmatians, demonstrates that canine red cell antigens beyond the DEA systems can elicit clinically relevant alloantibody responses after sensitization.

Related Clinical & Scientific Guides

• Toxicology in Emergency Practice: Common Poisons and Diagnostic Approach
• Veterinary Cardiopulmonary Resuscitation: Post-Cardiac Arrest Care
• Fluid Therapy Guidelines for Dogs and Cats: A Practical Update

References and Further Reading

• Increasing patient safety in veterinary transfusion medicine: an overview of pretransfusion testing.. 2009.
• Principles of transfusion medicine in small animals.. 2001.
• Canine Dal blood type: A red cell antigen lacking in some Dalmatians.. 2007.
• Xenotransfusion of anemic cats with blood compatibility issues: pre- and posttransfusion laboratory diagnostic and crossmatching studies.. 2016.
• An acute hemolytic transfusion reaction caused by dog erythrocyte antigen 1.1 incompatibility in a previously sensitized dog.. 1995.
• Feline transfusion medicine. Blood types and their clinical importance.. 1995.
• RECOVER Initiative Veterinary CPR Guidelines. Veterinary Emergency and Critical Care Society.
• AAHA/AAFP Fluid Therapy Guidelines for Dogs and Cats. AAHA.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Veterinary Blood Transfusion: Blood Types and Crossmatching
• Transfusion Triggers and Blood Product Selection in Anemic Dogs
• Veterinary Blood Transfusion: Administration and Monitoring
• Veterinary Plasma Transfusion: Indications and Administration
• Veterinary Whole Blood Transfusion: Collection and Storage

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.